Screening Plans & Options List

Yes, it is possible to undergo the screening, but there are a few important considerations. In the case of a vanishing twin, the DNA of the deceased fetus remains in the mother's blood for some time. Consequently, the risk of obtaining an inaccurate result (a result that differs from the actual status) is inevitably higher compared to a typical singleton pregnancy. At our clinic, we exceptionally perform the screening only for those who understand this risk of reduced accuracy and sign a consent form. Additionally, to maximize accuracy as much as possible, we ask that you undergo the test (blood draw) from the 10th week of pregnancy onwards. If you have any concerns or questions, please feel free to consult with our physicians or staff during your appointment.

Yes, highly accurate testing is performed across all plans. However, since the scope of testing varies by plan, please select the plan that best aligns with your goals.

These abnormalities can significantly affect a child's development and health after birth. Knowing about them in advance allows you to prepare appropriately.

It can detect chromosomal aneuploidies (such as trisomies 13, 18, and 21), sex chromosome abnormalities, full chromosome partial deletions/duplications, and microdeletion/duplication syndromes.

Our domestic testing is performed using data-driven benchmarks optimized for expectant mothers in Japan, accurately screening for full chromosome partial deletions/duplications as well as sex chromosome abnormalities.

It provides a broad understanding of the baby's health status before birth, enabling early preparation and the arrangement of appropriate medical support.